Bank of New York Mellon’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Bank of New York Mellon’s Portfolio CNST Stock Details CNST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-119,720	Closed	-$4.05M	–	4606
2021 Q2	$4.05M	Buy	119,720 +10,031	+9%	+$256K	﹤0.01%	2586
2021 Q1	$2.56M	Sell	109,689 -1,441	-1%	-$43.7K	﹤0.01%	2777
2020 Q4	$3.2M	Buy	111,130 +5,324	+5%	+$134K	﹤0.01%	2575
2020 Q3	$2.14M	Buy	105,806 +8,661	+9%	+$211K	﹤0.01%	2629
2020 Q2	$2.92M	Buy	97,145 +35,980	+59%	+$1.3M	﹤0.01%	2471
2020 Q1	$1.92M	Buy	61,165 +10,049	+20%	+$349K	﹤0.01%	2565
2019 Q4	$2.41M	Buy	51,116 +17,985	+54%	+$519K	﹤0.01%	2704
2019 Q3	$214K	Sell	33,131 -3,199	-9%	-$26.7K	﹤0.01%	3887
2019 Q2	$446K	Sell	36,330 -1,880	-5%	-$20.9K	﹤0.01%	3658
2019 Q1	$517K	Buy	+38,210	New	+$342K	﹤0.01%	3533

Bank of New York Mellon's CNST Position: Q3 2021 in Review

Bank of New York Mellon sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q3 2021, closing a stake of 119,720 shares — an estimated $4.05M sold.

Bank of New York Mellon first reported a position in CNST in Q1 2019 and held it in 10 quarters. The position peaked at $4.05M in Q2 2021. 0 funds tracked by Wall St. Rank hold CNST as of Q3 2021.

Bank of New York Mellon reported no remaining Constellation Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
Bank of New York Mellon sold 119,720 Constellation Pharmaceuticals, Inc. shares in Q3 2021, an estimated $4.05M.
Bank of New York Mellon first reported a position in Constellation Pharmaceuticals, Inc. in Q1 2019 and held it in 10 quarters.
Bank of New York Mellon's Constellation Pharmaceuticals, Inc. position peaked at $4.05M in Q2 2021.
0 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q3 2021.

Based on Bank of New York Mellon's 13F filing for Q3 2021, filed 12 Nov 2021.